ERBB2 and congestive heart failure: Then, Valachis A et al [31] investigated the cardiac toxicities with dual HER2 blockade and did not observed an increased the risk of CHF(OR 0.58, p=0.17) and LVEF decline (OR 0.88, p=0.64) with anti-HER2 combination.